<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">For the oncological outcome, the achievement of technical excellence in TME surgery at our center is reflected in the low local recurrence rates in both surgical groups when compared to other studies. For instance, a meta-analysis from 2015 suggested that compared to APER, LAR has better 5-year survival rates, lower CRM rates, less local recurrence and less complications [
 <xref ref-type="bibr" rid="CR18">18</xref>].
</p>
